Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Byondis B.V.

BC Partners Takes Control Of Synthon

Private-equity firm BC Partners has struck a deal to acquire a majority stake in Synthon International Holding.

Deals Strategy

Messy Rules For Non‐Biological Complex Drugs Under Fire

Calls are mounting for the EU to make the centralized procedure mandatory for follow-on versions of non‐biological complex drugs and for better regulatory alignment with the US and other countries.

Drug Review Europe

Forty Seven's IO Antibody Attracts Two Big Pharma Partners

Forty Seven Inc. has signed immuno-oncology deals with Merck of Germany and Roche that will see the launch of several combination studies for their PD-L1 inhibitors and Forty Seven's promising investigational CD47 antibody.

ImmunoOncology Deals

Europe Too: Approval Of A Higher Dose Glatiramer Generic

Like in the US, Teva's more convenient three-times-a-week dosage form of Copaxone is now facing competition in Europe from a generic, in this case one developed by the Netherlands' Synthon and Iceland's Alvogen.

Approvals Generic Drugs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Other Names / Subsidiaries
    • Synthon Biopharmaceuticals B.V.
UsernamePublicRestriction

Register